Filed: 8/14/2026ACC: 0001420506-26-001714
📋 What this filing means
EXOME ASSET MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 52 equity positions with a total reported market value of $162.10M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
52
Positions
$162.10M
Total AUM (reported)
6.42M
Total Shares
Allocation by class
COM$103.94M64.1%
COM NEW$24.95M15.4%
SPONSORED ADS$7.37M4.5%
SHS$6.95M4.3%
CL A$4.17M2.6%
CL A COM$3.93M2.4%
CLASS A ORD$3.24M2.0%
Portfolio Concentration
Top 3$28.30M17.5%
4–10$43.93M27.1%
11–25$50.43M31.1%
Rest$39.45M24.3%
Top 3 weight
17.5%
Top 10 weight
44.6%
Voting Authority Distribution
Total shares with voting rights: 6.42M
Sole
Full voting authority
6.42M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole52
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings52
Rows:
GUARDANT HEALTH INC
SOLEShares67.50K
TypeSH
Market value$10.13M
6.25%
Sole
67.50K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares27.20K
TypeSH
Market value$9.11M
5.62%
Sole
27.20K
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares164.91K
TypeSH
Market value$9.06M
5.59%
Sole
164.91K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares210.52K
TypeSH
Market value$8.15M
5.03%
Sole
210.52K
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares88.18K
TypeSH
Market value$6.99M
4.31%
Sole
88.18K
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares5.49K
TypeSH
Market value$6.59M
4.06%
Sole
5.49K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares46.88K
TypeSH
Market value$6.25M
3.85%
Sole
46.88K
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares204.42K
TypeSH
Market value$5.75M
3.55%
Sole
204.42K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares60.06K
TypeSH
Market value$5.12M
3.16%
Sole
60.06K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares100.20K
TypeSH
Market value$5.09M
3.14%
Sole
100.20K
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares97.28K
TypeSH
Market value$4.17M
2.57%
Sole
97.28K
Shared
0.00
None
0.00
UNITEDHEALTH GROUP INC
SOLEShares9.61K
TypeSH
Market value$4.00M
2.46%
Sole
9.61K
Shared
0.00
None
0.00
10X GENOMICS INC
SOLEShares102.63K
TypeSH
Market value$3.93M
2.43%
Sole
102.63K
Shared
0.00
None
0.00
NATERA INC
SOLEShares13.80K
TypeSH
Market value$3.75M
2.31%
Sole
13.80K
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares81.06K
TypeSH
Market value$3.73M
2.30%
Sole
81.06K
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares32.21K
TypeSH
Market value$3.58M
2.21%
Sole
32.21K
Shared
0.00
None
0.00
MAZE THERAPEUTICS INC
SOLEShares114.69K
TypeSH
Market value$3.42M
2.11%
Sole
114.69K
Shared
0.00
None
0.00
MONTE ROSA THERAPEUTICS INC
SOLEShares137.12K
TypeSH
Market value$3.32M
2.05%
Sole
137.12K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares166.49K
TypeSH
Market value$3.24M
2.00%
Sole
166.49K
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares61.34K
TypeSH
Market value$3.21M
1.98%
Sole
61.34K
Shared
0.00
None
0.00
LIQUIDIA CORPORATION
SOLEShares39.22K
TypeSH
Market value$3.13M
1.93%
Sole
39.22K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares5.41K
TypeSH
Market value$2.93M
1.81%
Sole
5.41K
Shared
0.00
None
0.00
GLAUKOS CORP
SOLEShares19.86K
TypeSH
Market value$2.78M
1.71%
Sole
19.86K
Shared
0.00
None
0.00
ARROWHEAD PHARMACEUTICALS IN
SOLEShares32.21K
TypeSH
Market value$2.63M
1.62%
Sole
32.21K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
SOLEShares70.50K
TypeSH
Market value$2.62M
1.61%
Sole
70.50K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
GUARDANT HEALTH INCSOLE | COM | 67.50K | SH | $10.13M 6.25% | 67.50K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 27.20K | SH | $9.11M 5.62% | 27.20K | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 164.91K | SH | $9.06M 5.59% | 164.91K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 210.52K | SH | $8.15M 5.03% | 210.52K | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 88.18K | SH | $6.99M 4.31% | 88.18K | 0.00 | 0.00 |
ELI LILLY & COSOLE | COM | 5.49K | SH | $6.59M 4.06% | 5.49K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 46.88K | SH | $6.25M 3.85% | 46.88K | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 204.42K | SH | $5.75M 3.55% | 204.42K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 60.06K | SH | $5.12M 3.16% | 60.06K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 100.20K | SH | $5.09M 3.14% | 100.20K | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 97.28K | SH | $4.17M 2.57% | 97.28K | 0.00 | 0.00 |
UNITEDHEALTH GROUP INCSOLE | COM | 9.61K | SH | $4.00M 2.46% | 9.61K | 0.00 | 0.00 |
10X GENOMICS INCSOLE | CL A COM | 102.63K | SH | $3.93M 2.43% | 102.63K | 0.00 | 0.00 |
NATERA INCSOLE | COM | 13.80K | SH | $3.75M 2.31% | 13.80K | 0.00 | 0.00 |
UNIQURE NVSOLE | SHS | 81.06K | SH | $3.73M 2.30% | 81.06K | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 32.21K | SH | $3.58M 2.21% | 32.21K | 0.00 | 0.00 |
MAZE THERAPEUTICS INCSOLE | COM | 114.69K | SH | $3.42M 2.11% | 114.69K | 0.00 | 0.00 |
MONTE ROSA THERAPEUTICS INCSOLE | COM | 137.12K | SH | $3.32M 2.05% | 137.12K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 166.49K | SH | $3.24M 2.00% | 166.49K | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 61.34K | SH | $3.21M 1.98% | 61.34K | 0.00 | 0.00 |
LIQUIDIA CORPORATIONSOLE | COM NEW | 39.22K | SH | $3.13M 1.93% | 39.22K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 5.41K | SH | $2.93M 1.81% | 5.41K | 0.00 | 0.00 |
GLAUKOS CORPSOLE | COM | 19.86K | SH | $2.78M 1.71% | 19.86K | 0.00 | 0.00 |
ARROWHEAD PHARMACEUTICALS INSOLE | COM | 32.21K | SH | $2.63M 1.62% | 32.21K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCSOLE | COM | 70.50K | SH | $2.62M 1.61% | 70.50K | 0.00 | 0.00 |
Page 1 of 3